Anti-CGRRF1 monoclonal antibody

Pre-made anti-CGRRF1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CGRRF1/CGRRF1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0540-Ab-1/ GM-Tg-hg-IP0540-Ab-2Anti-Human CGRRF1 monoclonal antibodyHuman
GM-Tg-rg-IP0540-Ab-1/ GM-Tg-rg-IP0540-Ab-2Anti-Rat CGRRF1 monoclonal antibodyRat
GM-Tg-mg-IP0540-Ab-1/ GM-Tg-mg-IP0540-Ab-2Anti-Mouse CGRRF1 monoclonal antibodyMouse
GM-Tg-cynog-IP0540-Ab-1/ GM-Tg-cynog-IP0540-Ab-2Anti-Cynomolgus/ Rhesus macaque CGRRF1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0540-Ab-1/ GM-Tg-felg-IP0540-Ab-2Anti-Feline CGRRF1 monoclonal antibodyFeline
GM-Tg-cang-IP0540-Ab-1/ GM-Tg-cang-IP0540-Ab-2Anti-Canine CGRRF1 monoclonal antibodyCanine
GM-Tg-bovg-IP0540-Ab-1/ GM-Tg-bovg-IP0540-Ab-2Anti-Bovine CGRRF1 monoclonal antibodyBovine
GM-Tg-equg-IP0540-Ab-1/ GM-Tg-equg-IP0540-Ab-2Anti-Equine CGRRF1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0540-Ab-1/ GM-Tg-hg-IP0540-Ab-2; GM-Tg-rg-IP0540-Ab-1/ GM-Tg-rg-IP0540-Ab-2;
GM-Tg-mg-IP0540-Ab-1/ GM-Tg-mg-IP0540-Ab-2; GM-Tg-cynog-IP0540-Ab-1/ GM-Tg-cynog-IP0540-Ab-2;
GM-Tg-felg-IP0540-Ab-1/ GM-Tg-felg-IP0540-Ab-2; GM-Tg-cang-IP0540-Ab-1/ GM-Tg-cang-IP0540-Ab-2;
GM-Tg-bovg-IP0540-Ab-1/ GM-Tg-bovg-IP0540-Ab-2; GM-Tg-equg-IP0540-Ab-1/ GM-Tg-equg-IP0540-Ab-2
Products NameAnti-CGRRF1 monoclonal antibody
Formatmab
Target NameCGRRF1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CGRRF1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0540-Ag-1Recombinant multi-species CGRF1/ CGRRF1/ CGR19 protein


    Target information

    Target IDGM-IP0540
    Target NameCGRRF1
    Gene ID10668,68755,116679,695231,100856669,101101477,534344,100056465
    Gene Symbol and Synonyms1110038G02Rik,1810009H17Rik,CGR19,CGRRF1,RNF197
    Uniprot AccessionQ99675,P97587
    Uniprot Entry NameCGRF1_HUMAN,CGRF1_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000100532
    Target ClassificationN/A

    The target: CGRRF1, gene name: CGRRF1, also named as CGR19, RNF197. Predicted to enable metal ion binding activity. Predicted to be involved in negative regulation of cell growth. Located in endoplasmic reticulum and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.